September 14, 2020
Multiple Sclerosis Research to Practice I: Neuropathology and Biomarkers
Jointly provided by Consortium of Multiple Sclerosis Centers and PlatformQ Health Education, LLC
- Physicians— maximum of 1 AMA PRA Category 1 Credit(s)™
- Nurses— 1 Nursing Contact Hours
- Pharmacists— 1 Contact Hours (0.1 CEUs)
This activity is supported by educational grants from Biogen, Genentech, and Sanofi Genzyme.
Neurologists, primary care physicians, advance practice clinicians, nursing professionals, pharmacists, and other healthcare professionals involved in the care of patients with MS.
- Summarize biomarkers in MS and their role in making treatment decisions
- Examine how biomarkers may be associated with disease development and progression, differences in patient symptoms, and response to treatment
In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC), and Platform Q Health Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Ellen M. Mowry, MD
Professor of Neurology and Epidemiology
Johns Hopkins University
Daniel Ontaneda, MD, MSc
Associate Professor of Neurology
Cleveland Clinic Lerner College of Medicine of Case Western